Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mokrane Yacoub

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
Differential expression of genes related to androgen and estrogen metabolism in hereditary versus sporadic prostate cancerGaelle Fromont, Mokrane Yacoub, Antoine Valeri, et al.
International Journal of Clinical Oncology|March 25, 2022
Incidental prostate cancer after holmium laser enucleation of the prostate: incidence and predictive factors for clinical progressionClément Klein, Thibault Marquette, Grégoire Capon, et al.
Pediatric Transplantation|March 19, 2026
Urothelial Carcinoma of the Bladder Following BK Virus Infection in a Pediatric Kidney Transplant RecipientMartina Ichas, Lise Allard, Luke Harper, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 30, 2010
Cyclophosphamide therapy for corticoresistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a patient with severe kidney and eye involvement and Epstein-Barr virus reactivationEmilie Laban, Eva Hainaut-Wierzbicka, François Pourreau, et al.
World Journal of Urology|June 23, 2025
Utility of restaging transurethral resection in patients with primary high-grade Ta bladder cancerSamy Mebroukine, Clément Klein, Mokrane Yacoub, et al.
Clinical Nuclear Medicine|June 28, 2019
68Ga-PSMA-617 Compared With 68Ga-RM2 and 18F-FCholine PET/CT for the Initial Staging of High-Risk Prostate CancerRomain Schollhammer, Henri de Clermont Gallerande, Grégoire Robert, et al.
Radiology|May 10, 2013
Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findingsFrançois Cornelis, Gérald Rigou, Yann Le Bras, et al.
Minerva Urology and Nephrology|February 16, 2026
Sutureless robotic-assisted partial nephrectomy: a propensity score-matched analysis (UroCCR N.158)Alexandre Blanco, Gaëlle Margue, Mokrane Yacoub, et al.
EJNMMI Research|April 9, 2025
Prostate-specific membrane antigen (PSMA) expression in primary and metastatic renal cell cancer (UroCCR-65 study)Salma Binzaqr, David Kryza, Anne-Laure Giraudet, et al.
EJNMMI Research|June 5, 2019
Comparison of the radiolabeled PSMA-inhibitor <sup>111</sup>In-PSMA-617 and the radiolabeled GRP-R antagonist <sup>111</sup>In-RM2 in primary prostate cancer samplesRomain Schollhammer, Henri De Clermont Gallerande, Mokrane Yacoub, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
Differential expression of genes related to androgen and estrogen metabolism in hereditary versus sporadic prostate cancerGaelle Fromont, Mokrane Yacoub, Antoine Valeri, et al.
International Journal of Clinical Oncology|March 25, 2022
Incidental prostate cancer after holmium laser enucleation of the prostate: incidence and predictive factors for clinical progressionClément Klein, Thibault Marquette, Grégoire Capon, et al.
Pediatric Transplantation|March 19, 2026
Urothelial Carcinoma of the Bladder Following BK Virus Infection in a Pediatric Kidney Transplant RecipientMartina Ichas, Lise Allard, Luke Harper, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 30, 2010
Cyclophosphamide therapy for corticoresistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a patient with severe kidney and eye involvement and Epstein-Barr virus reactivationEmilie Laban, Eva Hainaut-Wierzbicka, François Pourreau, et al.
World Journal of Urology|June 23, 2025
Utility of restaging transurethral resection in patients with primary high-grade Ta bladder cancerSamy Mebroukine, Clément Klein, Mokrane Yacoub, et al.
Clinical Nuclear Medicine|June 28, 2019
68Ga-PSMA-617 Compared With 68Ga-RM2 and 18F-FCholine PET/CT for the Initial Staging of High-Risk Prostate CancerRomain Schollhammer, Henri de Clermont Gallerande, Grégoire Robert, et al.
Radiology|May 10, 2013
Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findingsFrançois Cornelis, Gérald Rigou, Yann Le Bras, et al.
Minerva Urology and Nephrology|February 16, 2026
Sutureless robotic-assisted partial nephrectomy: a propensity score-matched analysis (UroCCR N.158)Alexandre Blanco, Gaëlle Margue, Mokrane Yacoub, et al.
EJNMMI Research|April 9, 2025
Prostate-specific membrane antigen (PSMA) expression in primary and metastatic renal cell cancer (UroCCR-65 study)Salma Binzaqr, David Kryza, Anne-Laure Giraudet, et al.
EJNMMI Research|June 5, 2019
Comparison of the radiolabeled PSMA-inhibitor <sup>111</sup>In-PSMA-617 and the radiolabeled GRP-R antagonist <sup>111</sup>In-RM2 in primary prostate cancer samplesRomain Schollhammer, Henri De Clermont Gallerande, Mokrane Yacoub, et al.
Pageof 4